ErbB4 has emerged as a leading susceptibility gene for schizophrenia but the function of the ErbB4 receptor in the adult brain is unknown. Here, we show in the adult hippocampus that long-term potentiation (LTP) of transmission at Scha¡er collateral CA1 synapses was markedly enhanced in mutant mice lacking ErbB4. Concordantly, LTP was enhanced by acutely blocking ErbB4 in wild-type animals, indicating that ErbB4 activity constitutively suppresses LTP. Moreover, increasing ErbB4 signaling further suppressed LTP. By contrast, altering ErbB4 activity did not a¡ect basal synaptic transmission or short-term facilitation. Our ¢ndings suggest that cognitive de¢cits in schizophrenia may be a consequence of hyperfunction of ErbB4 signaling leading to suppressed glutamatergic synaptic plasticity, thus opening new approaches for the treatment of this disorder. NeuroReport 19:139^143
Introduction
A growing body of linkage and association evidence in humans implicates ErbB4 as a leading susceptibility gene for schizophrenia [1, 2] , but a critical unresolved issue is defining the essential functions of ErbB4 in the brain and the link to schizophrenia [3] . As deficits in cognition are a core feature of schizophrenia [4] and because a critical cellular substrate for normal cognitive functioning is synaptic plasticity at glutamatergic synapses [5] , we used a loss-of-function approach to investigate the hypothesis that ErbB4 may function to regulate glutamatergic synaptic transmission or plasticity.
ErbB4 is expressed in the adult central nervous system [6] and in the adult hippocampus, a brain region increasingly, implicated in schizophrenia [1, 7, 8] , ErbB4 is abundantly expressed by pyramidal cells (e.g. [9] [10] [11] and Fig. 1a -c) and is enriched at glutamatergic synapses in the postsynaptic density [10] . ErbB4 associates with the scaffolding protein PSD-95 [9, 10, 12] and through this with the N-methyl-Daspartate (NMDA) receptor [9, 10, 12] , a subtype of a glutamate receptor having a key role in synaptic plasticity. Our evidence indicates that tonic activity of ErbB4 constitutively suppresses long-term potentiation (LTP) of glutamatergic synaptic transmission in the adult hippocampus. Our findings reveal a previously unknown essential function of ErbB4 in the brain, suggesting that cognitive deficits in schizophrenia may be a consequence of hyperfunction of ErbB4 signaling thereby suppressing plasticity at glutamatergic synapses.
Methods
ErbB4 null mutant mice ErbB4 null mice were kindly provided by Martin Gassmann [13] . Embryonic lethality of ErbB4 À/À mice was genetically rescued by expressing ErbB4 under a cardiac-specific myosin promoter (ErbB4 À/À HER4 heart ). These mice did not express ErbB4 in the brain or noncardiac tissues.
Immunocytochemistry
Anesthetized adult male ErbB4 + / + HER4 heart and ErbB4 À/À HER4 heart mice were perfused transcardially with 4% paraformaldehyde. Brains were removed, post-fixed, and placed in 30% sucrose. Parasagittal 50 mm frozen sections were collected in cold 0.1 M phosphate-buffered saline and stained with Nissl or processed for immunohistochemistry using anti-NeuN antibody (1 : 2000, Chemicon) or anti-ErbB4 antibody (SC-283, Santa Cruz Biotechnology, Inc., Santa Cruz, California, USA; 1 : 500, Santa Cruz Biotechnology) with or without its immunogenic peptide. Immunostaining was revealed using fluorescently conjugated secondary antibodies.
Immunoblotting
Hippocampal or heart tissue from ErbB4 + / + HER4 heart and ErbB4 À/À HER4 heart mice was homogenized in buffer (in mM): 20 Tris-HCl, pH 8, 137 NaCl, 1% NP-40, 10% glycerol, and the protease inhibitor cocktail (Sigma, http:// www.sigmaaldrich.com). Proteins were resolved in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred onto a nitrocellulose membrane, and visualized using enhanced chemiluminescence. Antibodies used were ErbB4 (Cell Signaling Technology, Inc., Boston, Massachusetts, USA) and b-actin (Sigma, http://www.sigmaaldrich.com).
Electrophysiology
Hippocampal slices (300 mm) prepared from anesthetized (20% urethane, intraperitoneally) approximately 20-weekold ErbB4 + / + HER4 heart (n¼4 mice) or ErbB4 À/À HER4 heart (n¼4 mice) mice or 21-day-old male Sprague-Dawley rats (Charles River) were placed in a holding chamber for Z1 h prior to recording. A single slice was then transferred to a recording chamber and superfused with artificial cerebral spinal fluid (ACSF; at 2 ml/min) composed of (in mM): 132 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , 11 D-glucose, 20 NaHCO 3 , and 2 CaCl 2 saturated with 95% O 2 (balance 5% CO 2 ) at 28721C (pH 7.40; 315-325 mOsm). ACSF was supplemented with bicuculline methiodide (5 mM). Field excitatory postsynaptic potentials (fEPSPs) were evoked using bipolar tungsten electrodes located approximately 50 mm from the CA1 cell body layer and were recorded using ACSF-filled glass micropipettes placed in the stratum radiatum 60-80 mm from the cell body layer. Stimulation of Schaffer collateral afferents consisted of single pulses (0.08 ms duration) at 0.1 Hz; intensity was set to 30-35% of that which produced maximum synaptic responses. Theta burst stimulation consisted of 15 bursts of four pulses at 100 Hz, delivered at an interstimulus interval of 200 ms. ACSF was supplemented as indicated with neuregulin-1b, NRG-1b, (2 nM), which was stored as single-use aliquots in an aqueous solution at À801C. ACSF was also supplemented as indicated with PD158780 (10 mM; dissolved in DMSO), which was made fresh immediately before the experiment. fEPSP slope was calculated as the slope of the 10-60% rising phase. Raw data were amplified using a MultiClamp 700A (http://www.moleculardevices.com) amplifier and a Digidata 1322A acquisition system (Sunnyvale, California, USA) sampled at 10 Hz, and analyzed with Clampfit 9.0 and Sigmaplot (http://www.systat.com) 7 software. Recordings were made with the experimenter being blind to mouse genotype. Statistical comparison of data, presented as mean (7SEM), was done using two-way analysis of variance with the Tukey Test. Experiments were in accordance with policies of The Hospital for Sick Children Animal Care Committee and the Canadian Council on Animal Care.
Results
In our experiments we used mutant mice [13] in which ErbB4 had been deleted but in which expression of the human ErbB4 was driven in the heart by the a-myosin heavy chain promoter (ErbB4 À/À HER4 heart ), which rescued an otherwise lethal cardiac defect ( Fig. 1d ). In adult ErbB4 À/À HER4 heart mice, we found that the size, anatomy, and gross morphology of the hippocampus were not different from wild-type littermate controls (ErbB4 + / + HER4 heart ; Fig. 1e ). Moreover, in electrophysiological recordings using adult ErbB4 À/À HER4 heart mice, we found that at Schaffer collateral CA1 synapses in acute hippocampal slices, the basal stimulus-response relationships for afferent fiber volleys and fEPSPs ( Fig. 2a ,b) and for paired-pulse facilitation, a measure of presynaptic function ( Fig. 2c ), were not different from wild-type littermates. We then investigated synaptic plasticity at these synapses by studying LTP induced by theta-burst stimulation (TBS), a stimulation paradigm mimicking the endogenous theta rhythm that is critical for normal cognitive processing [14] . We found that theta-burstinduced LTP (tbLTP) was dramatically increased in the ErbB4 À/À HER4 heart mice ( Fig. 2d ): in ErbB4 mutant animals fEPSP slope was 210720% (n¼14) 60 min after TBS compared with 16276% (n¼14) in wild-type mice (Po0.01). Thus, although ErbB4 À/À HER4 heart mice had no abnormality of basal synaptic transmission or presynaptic function, they showed greatly increased tbLTP. Therefore, these findings indicate that ErbB4 genetically suppresses a prominent form of synaptic plasticity at Schaffer collateral CA1 synapses.
To determine whether the enhancement of tbLTP seen in the ErbB4 À/À HER4 heart mice was due to loss of ErbB4 signaling in the adult or to an abnormality due to lack of ErbB4 during development, we examined the effect of acutely inhibiting ErbB4 receptors on tbLTP in normal adult animals. For this purpose, we used the potent and membrane-permeable ErbB kinase inhibitor, PD158780, which is known to prevent receptor autophosphorylation and signaling [15] . We found that bath-applied PD158780
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Heart (10 mM) had no effect on volley amplitude, basal fEPSPs, or on paired-pulse facilitation (Fig. 3a-c) . tbLTP, however, was greatly enhanced in slices treated with PD158780 ( Fig. 3d ): with PD158780 application fEPSP slope was 189711% (n¼21) 60 min after TBS compared with 14974% (n¼13) in control, untreated slices (Po0.001). As PD158780 may act on ErbB receptors in addition to ErbB4, we tested it in slices from ErbB4 À/À HER4 heart mice and found that it had no effect on tbLTP (data not illustrated), indicating that the enhancement of tbLTP by PD158780 is dependent upon ErbB4. Thus, in the adult hippocampus ErbB4 signaling constitutively suppresses synaptic plasticity.
To determine whether increasing ErbB4 signaling beyond the constitutive level may further suppress tbLTP we compared the effect of neuregulin, NRG-1b, an agonist for receptors of the ErbB family, in ErbB4 À/À HER4 heart versus wild-type mice. We and others have shown that NRG-1b impairs synaptic plasticity [10, 16, 17] . We found here that bath-applying NRG-1b (2 nM) nearly abolished tbLTP in slices from wild-type mice but had no effect on tbLTP in those from ErbB4 À/À HER4 heart mice (Fig. 3e) , indicating that NRG-1b inhibits tbLTP through activating ErbB4. Importantly, NRG-1b had no effect on basal synaptic transmission or paired-pulse facilitation (Fig. 3a-c) and PD158780 prevented the suppression of tbLTP by applying NRG-1b in slices from normal animals (Fig. 3f ). Thus, under basal conditions the effect of ErbB4 signaling on tbLTP is not maximal in normal animals, and causing hyperfunction in this signaling pathway further suppresses synaptic plasticity.
Discussion
To study the nonredundant functions of ErbB4 in the hippocampus we used ErbB4 À/À HER4 heart mice. We found that basal synaptic transmission and paired-pulse facilitation were not different from wild type whereas LTP was increased in the mice lacking ErbB4. There were no detectable developmental abnormalities in the hippocampus of the ErbB4 mutant mice that might have accounted for this enhanced LTP, and moreover, acutely administering PD158780 to adult hippocampal slices from wild-type animals was without an effect on basal synaptic transmission but caused an increase in LTP. We note that the increase in LTP by PD15870 appears to be mediated by the blockade of ErbB4 as this compound had no effect on LTP in the ErbB4 mutant mice. The cognate ligand for ErbB4 receptors is NRG1 [18] and we found that the suppression of LTP by administering NRG-1b [10, 16, 17] was prevented in the ErbB4 mutant mice and also by PD158780. The most parsimonious explanation for these findings taken together is that a nonredundant function of NRG1-ErbB4 signaling in the hippocampus is to constitutively suppress LTP at Schaffer collateral CA1 synapses. Theta-burst stimulation (TBS) was delivered to Scha¡er collateral CA1synapses at the 30 min time point. fEPSP slope was normalized with respect to the mean slope of fEPSPs recorded during the 10 min period immediately beforeTBS. Inset: average of six consecutive fEPSPs recorded before or after TBS ('a' or 'b', respectively; scale bars: 10 ms, 0.5 mV). Po0.01, ErbB4 + / + HER4 heart vs. ErbB4 À/À HER4 heart , 60 min afterTBS.
The enhancement of LTP in the ErbB4 null mutant mice, and the enhancement by acutely administering PD158780, is consistent with predictions from the suppression of LTP produced by administering exogenous NRG-1b [10, 16, 17] . Recently, it has been reported in hippocampal slice cultures that synaptic spine density and pairing-induced LTP are reduced by decreasing the expression of ErbB4 or by overexpressing a kinase dead ErbB4 mutant [19] . Although it is conceivable that the difference between this study and those in which NRG-1b was administered as possibly due to exogenous NRG-1b not mimicking the endogenous ligand [19] , this explanation cannot account for the enhancement of LTP seen presently in the mice lacking ErbB4 nor the enhancement by applying PD158780. Rather, the apparently divergent results may reflect differences between acute slices and cultures, or between NRG1-ErbB4 signaling during development as opposed to in the adult.
ErbB4 receptors are known to be expressed by g-amino-nbutyric acid (GABA)ergic neurons [20] and activation of ErbB4 enhances presynaptic release of GABA in prefrontal cortex [21] . In this present study, recordings were carried out in the presence of the GABA A receptor antagonist, bicuculline. Thus, our findings are independent of GABA Amediated inhibitory mechanisms.
Both ErbB4 and NRG1 have emerged as leading susceptibility genes for schizophrenia [2, 22, 23] . One prominent hypothesis regarding the pathogenesis of schizophrenia is NMDA receptor hypofunction [24, 25] . Recently, it has been found in postmortem prefrontal cortex in schizophrenia that NRG1-ErbB4 signaling is enhanced and that there is increased NRG1-induced attenuation of NMDA receptor signaling [12] . We have found in mice and rats that a constitutive function of ErbB4 is to suppress activitydependent glutamatergic synaptic plasticity without altering synaptic transmission per se and that this plasticity, which is NMDA receptor-dependent, can be further suppressed by enhancing NRG1-ErbB4 signaling. Taken together, we propose that a cellular substrate for the cognitive dysfunction in schizophrenia is suppression of the plasticity of glutamatergic synaptic transmission by a gain-of-function of NRG1-ErbB4 signaling.
Conclusion
We find that NRG1-ErbB4 signaling constitutively suppresses LTP at Schaffer collateral synapses in CA1 hippocampus without affecting basal synaptic transmission. This provides a unifying concept for understanding the mechanistic basis of schizophrenia risk pathways in that cognitive deficits may result from excessive function of NRG1-ErbB4 signaling further suppressing synaptic plasticity. Interfering with the suppression of synaptic plasticity caused by NRG1-ErbB4 signaling thus represents a novel strategy for treatment of this prevalent and disabling disorder. and PD158780 -treated (¢lled circles, n¼21; in ACSF beginning 25 min be-foreTBS with ¢nal concentration of 10 mM) slices from rats. Inset: average of six consecutive fEPSPs recorded before or after TBS ('a' or 'b', respectively; scale bars: 10 ms, 0.6 mV). Po0.001, control vs. PD158780, 60 min after TBS. (e) Histogram shows TBS-induced increase in fEPSP slope 60 min after TBS in slices from ErbB4 + / + HER4 heart (white bar) and ErbB4 À/À HER4 heart (dark grey bar) mice without (À) and with ( + ; black bars) NRG-1b treatment (in ACSF beginning 20 min beforeTBS with ¢nal concentration of 2 nM). Results are expressed as a percentage of TBS-induced increase in fEPSP slope (% tbLTP) with tbLTP in ErbB4 + / + HER4 heart slices (white bar) normalized to100%. ***Po0.001vs. ErbB4 + / + HER4 heart (white bar); Po0.05, ErbB4 À/À HER4 heart /NRG-1b (black bar) vs. ErbB4 + / + HER4 heart (white bar). (f) Histogram shows normalized TBS-induced mean increase in fEPSP slope in control (white bar) and PD158780 -treated slices (light grey bar) without (À) and with (+; black bars) NRG-1b (2 nM administered as above). ***Po0.001vs. control (white bar); Po0.01, PD158780/NRG-1b (black bar) vs. control (white bar). Data are taken 60 min afterTBS.
